Ladenburg Thalmann Initiates Coverage of PSS World Medical (PSSI) With A Buy Rating
More News related to PSSI
- PSS World (PSSI) Posts Q2 adj.-EPS of $0.39
- PSS World Medical Reports Results for Fiscal Year 2010 Second Quarter
- Trading Radar for 10/28: First Solar (FSLR), ConocoPhillips (COP), WellPoint (WLP), Goodyear (GT), Int. Paper (IP) Report
- PSS World Medical to Broadcast Its Fiscal 2010 Second Quarter Conference Call Live On the Internet
- StockPreacher.com Issues Trading Outlook for American Scientific Resources Inc.
Ladenburg Thalmann initiates coverage of PSS World Medical (Nasdaq: PSSI) with a Buy Rating and a $25 price target.
To see more ratings related to PSSI, click here.
Related Categories
New CoverageStocks Mentioned
-0.29Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
